Survival analysis showed that high RPPH1 expression was associated with poor overall survival (OS; p < 0.001) and disease-free survival (DFS) in CRC patients (p = 0.001; Fig. 1h, i). The gene discussed is RPPH1; the disease is colorectal carcinoma.